4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow ganirelix: new trials by email Literature Review of ganirelix trials Research Report on ganirelix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antagonist/Letrozole in Poor Responders letrozole, oral contraceptive (Marvelone), GnRH agonist (buserelin) - Ovarian Stimulation | Phase 1 / Phase 2 | Completed | Yazd Research & Clinical Center for Infertility | 120 | 2008-06-01 | 2013-12-23 |
| Sex Hormones and Orthostatic Tolerance Ganirelix acetate, 17β-Oestradiol, Progesterone - Orthostatic Intolerance | Phase 2 | Completed | Yale University | 109 | 2006-02-01 | 2018-12-13 |
| Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED) Ganirelix - Controlled Ovarian Stimulation | Phase 2 | Completed | Organon and Co | 266 | 2003-02-03 | 2024-08-15 |
| Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015) Org 36286, Puregon®, Orgalutran® - Infertility, In Vitro Fertilization | Phase 2 | Completed | Organon and Co | 99 | 2001-07-01 | 2024-08-15 |
Infertility (1) · Orthostatic Intolerance (1)
Organon and Co (2) · Yale University (1) · Yazd Research & Clinical Center for Infertility (1)
Iran (1) · United States (1)
R01HL071159 (1)